(189 days)
Not Found
No
The description details a standard in vitro diagnostic assay based on chemical reactions and optical measurements, with no mention of AI or ML algorithms for data analysis or interpretation.
No
Explanation: The device is an in vitro diagnostic (IVD) device used for measuring Hemoglobin A1c, a diabetes marker, for monitoring long-term glycemic control. It is not designed to treat or prevent a disease, but rather to provide diagnostic information.
Yes
The "Intended Use / Indications for Use" section explicitly states "The ADVIA® Chemistry Hemoglobin A1c method is for in vitro diagnostic use in the quantitative determination of Hemoglobin A1c...".
No
The device description clearly outlines the use of reagents, whole blood samples, and a chemistry system (ADVIA Chemistry Systems) to perform the analysis. This involves physical components and chemical processes, not solely software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use Statement: The very first sentence of the "Intended Use / Indications for Use" section explicitly states: "The ADVIA® Chemistry Hemoglobin A1c method is for in vitro diagnostic use in the quantitative determination of Hemoglobin A1c..."
- Purpose: The device is used to measure Hemoglobin A1c in whole blood, which is a "diabetes marker" used for "monitoring the long-term glycemic control of persons with diabetes." This is a diagnostic purpose performed outside of the body.
- Sample Type: The device analyzes "whole blood," which is a biological sample taken from a patient.
- Methodology: The description details laboratory-based methods like latex agglutination inhibition and conversion of hemoglobin derivatives, which are typical for in vitro diagnostic tests.
- Calibrators: The device uses calibrators specifically designed for "in vitro diagnostic use in the calibration of the A1c and total hemoglobin methods."
- Performance Studies: The document describes performance studies (imprecision, method comparison, interfering substances, etc.) which are standard for demonstrating the analytical performance of an IVD.
- Predicate Device: The mention of predicate devices (other IVDs) further confirms that this device falls within the category of in vitro diagnostics.
N/A
Intended Use / Indications for Use
The ADVIA® Chemistry Hemoglobin A1c method is for in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on the ADVIA Chemistry systems. Such measurements are used for monitoring the long-term glycemic control of persons with diabetes. The A1c and total hemoglobin (tHb) values generated as part of the HbA1cN and HbA1cI results are intended for use in the calculation of the A1c / total hemoglobin ratio, and must not be used individually for diagnostic purposes.
*Note: HbA1cN reports HbA1c in % and HbA1cI reports HbA1c in mmol/mol
The ADVIA® Chemistry A1c Calibrators are for in vitro diagnostic use in the calibration of the A1c and total hemoglobin methods (Automated and Manual Pretreatment) on the ADVIA Chemistry Systems.
Product codes (comma separated list FDA assigned to the subject device)
LCP, JIX
Device Description
The concentration of A1c and the concentration of total hemoglobin are measured and the ratio is reported (either as % or mmol/mol).
There are two different sample pretreatment methods available on the ADVIA Chemistry System. The first method is an Automated Pretreatment that uses 4 reagents: A1c Denaturant Reagent, Total Hemoglobin Reagent (tHb 2), A1c Agglutinator Reagent (R1) and A1c Antibody Reagent (R2). In this Automated Pretreatment step, the whole blood sample is mixed with the A1c Denaturant Readent. The red blood cells are lysed and the hemoglobin chains are hydrolyzed by the protease present in the reagent.
The second method is a Manual Pretreatment that uses the same reagents as the first method except that the A1c Denaturant Reagent is replaced with the Hemoglobin Denaturant Reagent. For this method, there is an off-line pretreatment that is followed bv a 10 minute incubation.
For the measurement of total hemoglobin, the Total Hemoglobin Reagent is used. The method is based on the conversion of all hemoglobin derivatives into alkaline hematin in an alkaline solution of a nonionic detergent
A latex agglutination inhibition method is used for the measurement of specific A1c. The A1c present in the sample competes with the agglutinator (synthetic latex containing multiple copies of the immunoreactive portion of A1c) for the anti-A1c antibody; thereby reducing the rate of agglutination. A concentration curve is obtained by monitoring the change in scattered light as a change of absorbance. The actual change in absorbance is inversely proportional to the concentration of A1c in the sample. The HbA1cN NGSP result (%) or the HbA1cl IFCC result (mmol/mol) is calculated using the A1c and total hemoglobin values.
The ADVIA® Chemistry A1c Calibrators are used to calibrate the methods. The calibrators consist of four (4) levels of lyophilized whole blood containing varying concentrations of HbA1c and total hemoglobin. There is a single level calibration for total hemoglobin (Cal 1) and a multi-level calibration (six levels) for A1c. Four calibrator levels (designated Cal 1 - 4) are provided in a single kit and each level is 0.5 g/vial. The other two levels consist of Saline (Cal 0) and Cal 5 (prepared by the system from Cal 4 using 1.4 times the volume used for Cal 4).
The target value of each calibrator (calibration) level is:
- Calibration Level 1 (Cal 0): 0.00 umol/L A1c, 0.0 g/dL Total Hemoglobin ●
- Calibration Level 2 (Cal 1): 2.30 µmol/L A1c, 11.0 g/dL Total Hemoglobin .
- Calibration Level 3 (Cal 2): 3.65 umol/L A1c .
- Calibration Level 4 (Cal 3): 5.15 umol/L A1c .
- Calibration Level 5 (Cal 4): 6.80 umol/L A1c .
- Calibration Level 6 (Cal 5): 8.20 umol/L A1c
Storage is at 2 - 8°C.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Substantial equivalence was demonstrated by testing several performance characteristics including imprecision, method comparison, interfering substances, matrix equivalency, and analytical range. All of the evaluation studies gave acceptable results compared to the Predicate Device. These studies support that the ADVIA Chemistry Hemoglobin A1c assay (with the ADVIA Chemistry A1c Calibrators) is substantially equivalent to the Tosoh G7 HPLC Hemoglobin A1c method that is currently marketed.
Imprecision:
ADVIA Chemistry Hemoglobin A1c ADVIA 1800 - Automated:
Level HbA1c (%): 5.5, Total CV (%): 1.9
Level HbA1c (%): 9.6, Total CV (%): 1.3
ADVIA Chemistry Hemoglobin A1c ADVIA 1800 - Manual:
Level HbA1c (%): 5.0, Total CV (%): 1.9
Level HbA1c (%): 8.8, Total CV (%): 1.4
Tosoh G7 HPLC HbA1c:
Level HbA1c (%): 5.8, Total CV (%): 1.12
Level HbA1c (%): 10.9, Total CV (%): 0.71
Correlation (y = ADVIA Chemistry Hemoglobin A1c, x = comparison method/system):
System (y): ADVIA 1800 Automated – Least Squares, N: 80, Regression Equation: y = 0.98x + 0.17, r: 0.997, Sy.x: 0.17, Sample Range (%): 4.40 - 12.60
System (y): ADVIA 1800 Automated – Passing Bablok / Pearson's, N: 80, Regression Equation: y = 1.00x + 0.06, r: 1.00, Sy.x: --, Sample Range (%): 4.40 - 12.60
System (y): ADVIA 1800 Manual – Least Squares, N: 80, Regression Equation: y = 0.95x + 0.26, r: 0.995, Sy.x: 0.19, Sample Range (%): 4.40 - 12.60
System (y): ADVIA 1800 Manual – Passing Bablok / Pearson's, N: 80, Regression Equation: y = 0.97x + 0.10, r: 1.00, Sy.x: --, Sample Range (%): 4.40 - 12.60
x = NGSP Reference Method (Tosoh G7), y = ADVIA Chemistry System
Interfering Substances (ADVIA Chemistry Hemoglobin A1c on ADVIA 1800)
Automated Sample Pretreatment:
Interfering Substance: Triglycerides (Intralipid), Interferent Conc. (mg/dL): 500, HbA1c conc. (%): 5.2, Effect (% change): - 7.8
Interfering Substance: Bilirubin, free, Interferent Conc. (mg/dL): 60, HbA1c conc. (%): 5.3, Effect (% change): - 1.9
Interfering Substance: Bilirubin, conjugated, Interferent Conc. (mg/dL): 60, HbA1c conc. (%): 5.2, Effect (% change): - 3.8
Manual Sample Pretreatment:
Interfering Substance: Triglycerides (Intralipid), Interferent Conc. (mg/dL): 500, HbA1c conc. (%): 5.2, Effect (% change): - 7.7
Interfering Substance: Bilirubin, free, Interferent Conc. (mg/dL): 60, HbA1c conc. (%): 5.1, Effect (% change): - 2.0
Interfering Substance: Bilirubin, conjugated, Interferent Conc. (mg/dL): 60, HbA1c conc. (%): 5.1, Effect (% change): - 5.9
Interfering Substance: Rheumatoid Factor, Interferent Conc. (mg/dL): 1100 IU/mL, HbA1c conc. (%): 4.8, Effect (% change): 0
Analytical Range:
Platform: All ADVIA Chemistry: 2.9 - 15.4% (As depicted in Method Differences table)
The text mentions "Calibrator Level 6 - (12-3-18.6%)" as possibly related to analytical range, but the table "Analytical Range" for "All ADVIA Chemistry" explicitly states "2.9 - 15.4%". This second value seems to indicate the range supported by the calibrator levels, though it is not explicitly labeled as such in the table. Given the direct "Analytical Range" table entry, I will use that.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 864.7470 Glycosylated hemoglobin assay.
(a)
Identification. A glycosylated hemoglobin assay is a device used to measure the glycosylated hemoglobins (A1a , A1b , and A1c ) in a patient's blood by a column chromatographic procedure. Measurement of glycosylated hemoglobin is used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of glycosylated hemoglobin indicate uncontrolled diabetes in a patient.(b)
Classification. Class II (performance standards).
0
510(k) Summary
JAN - 8 2009
| Submitter information
Contact person: | Philip Liu
Manager, Regulatory Affairs & Compliance | | |
|-----------------------------------------------------|------------------------------------------------------------------------------|---------------------------------------------------------------------------|--|
| Address: | Siemens Healthcare Diagnostics
511 Benedict Avenue
Tarrytown, NY 10591 | | |
| Phone: | 914-524-2443
914-524-2500 (fax) | | |
| Date summary prepared: | November 12, 2008 | | |
| Device Trade or Proprietary Names: | | ADVIA® Chemistry Hemoglobin A1c Assay
ADVIA® Chemistry A1c Calibrators | |
| Device Common/Usual Name or
Classification Name: | | Glycosylated Hemoglobin Assay
Calibrators | |
| Classification Number/Class: | | LCP / Class II | |
JIX / Class II
This 510(k) summary of safety and effectiveness is being submitted in accordance with the requirements of 21 CFR 807.92.
The assigned 510(k) number is: _k081895
Assay Predicate Device:
| Predicate Device | ||
|---|---|---|
| Device Name | G7 Automated HPLC Analyzer - HbA1c Variant Analysis Mode | |
| Common name | Glycosylated Hemoglobin Test | |
| 510(k) Number | K011434 | |
| Manufacturer | Tosoh Medics, Inc. |
Calibrator Predicate Device:
| Predicate Device | ||
|---|---|---|
| Device Name | VITROS Chemistry Products Calibrator Kit 18 | |
| Common name | Calibrator | |
| 510(k) Number | K041764 | |
| Manufacturer | Ortho-Clinical Diagnostics |
Siemens Healthcare Diagnostics (formerly Siemens Medical Solutions Diagnostics) ADVIA Chemistry Hemoglobin A1c Assay and Calibrators Premarket Notification - 510(k) 510(k) Summary
1
Device Description:
The concentration of A1c and the concentration of total hemoglobin are measured and the ratio is reported (either as % or mmol/mol).
There are two different sample pretreatment methods available on the ADVIA Chemistry System. The first method is an Automated Pretreatment that uses 4 reagents: A1c Denaturant Reagent, Total Hemoglobin Reagent (tHb 2), A1c Agglutinator Reagent (R1) and A1c Antibody Reagent (R2). In this Automated Pretreatment step, the whole blood sample is mixed with the A1c Denaturant Readent. The red blood cells are lysed and the hemoglobin chains are hydrolyzed by the protease present in the reagent.
The second method is a Manual Pretreatment that uses the same reagents as the first method except that the A1c Denaturant Reagent is replaced with the Hemoglobin Denaturant Reagent. For this method, there is an off-line pretreatment that is followed bv a 10 minute incubation.
For the measurement of total hemoglobin, the Total Hemoglobin Reagent is used. The method is based on the conversion of all hemoglobin derivatives into alkaline hematin in an alkaline solution of a nonionic detergent
A latex agglutination inhibition method is used for the measurement of specific A1c. The A1c present in the sample competes with the agglutinator (synthetic latex containing multiple copies of the immunoreactive portion of A1c) for the anti-A1c antibody; thereby reducing the rate of agglutination. A concentration curve is obtained by monitoring the change in scattered light as a change of absorbance. The actual change in absorbance is inversely proportional to the concentration of A1c in the sample. The HbA1cN NGSP result (%) or the HbA1cl IFCC result (mmol/mol) is calculated using the A1c and total hemoglobin values.
The ADVIA® Chemistry A1c Calibrators are used to calibrate the methods. The calibrators consist of four (4) levels of lyophilized whole blood containing varying concentrations of HbA1c and total hemoglobin. There is a single level calibration for total hemoglobin (Cal 1) and a multi-level calibration (six levels) for A1c. Four calibrator levels (designated Cal 1 - 4) are provided in a single kit and each level is 0.5 g/vial. The other two levels consist of Saline (Cal 0) and Cal 5 (prepared by the system from Cal 4 using 1.4 times the volume used for Cal 4).
The target value of each calibrator (calibration) level is:
- Calibration Level 1 (Cal 0): 0.00 umol/L A1c, 0.0 g/dL Total Hemoglobin ●
- Calibration Level 2 (Cal 1): 2.30 µmol/L A1c, 11.0 g/dL Total Hemoglobin .
- Calibration Level 3 (Cal 2): 3.65 umol/L A1c .
- Calibration Level 4 (Cal 3): 5.15 umol/L A1c .
- Calibration Level 5 (Cal 4): 6.80 umol/L A1c .
- Calibration Level 6 (Cal 5): 8.20 umol/L A1c
Siemens Healthcare Diagnostics (formerly Siemens Medical Solutions Diagnostics) ADVIA Chemistry Hemoglobin A1c Assay and Calibrators Premarket Notification - 510(k) 510(k) Summary
2
Storage is at 2 - 8°C.
CAUTION! POTENTIAL BIOHAZARD: Contains human source material. While each human serum or plasma donor unit used in the manufacture of this product was tested by FDA-approved methods and found nonreactive for hepatitis B surface antigen (HBsAg), antibody to hepatitis C (HCV), and antibody to HIV-1/2, all products manufactured using human source material should be handled as potentially infectious. Because no test method can offer complete assurance that hepatitis B or C viruses, HIV, or other infectious agents are absent, these products should be handled according to established good laboratory practices.
Statement of Intended Use:
The ADVIA® Chemistry Hemoglobin A1c method is for in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on the ADVIA Chemistry systems. Such measurements are used for monitoring the long-term alvcemic control of persons with diabetes. The A1c and total hemoglobin (tHb) values generated as part of the HbA1cN and HbA1cl methods are intended for use in the calculation of the A1c / total hemoglobin ratio, and must not be used individually for diagnostic purposes.
*Note: HbA1cN reports HbA1c in % and HbA1cl reports HbA1c in mmol/mol
The ADVIA® Chemistry A1c Calibrators are for in vitro diagnostic use in the calibration of the A1c and total hemoglobin methods (Automated and Manual Pretreatment) on the ADVIA Chemistry Systems.
Comparisons to the Predicate Device:
Method Similarities
| | ADVIA Chemistry
Hemoglobin A1c
( new device ) | Tosoh G7 Automated HPLC Analyzer
- HbA1c Variant Analysis Mode
( predicate device ) |
|-----------------|-----------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|
| Intended Use | For in vitro diagnostic use for the
measurement of hemoglobin A1c | For in vitro diagnostic use for the
measurement of hemoglobin A1c |
| Specimen Type | Human Whole Blood
(EDTA and Lithium Heparin) | Human Whole Blood |
| Standardization | Traceable to NGSP***
Traceable to IFCC by Master Equation | Traceable to NGSP*** |
3
Method Differences
| | ADVIA Chemistry
Hemoglobin A1c
(new device) | Tosoh G7 Automated HPLC Analyzer
- HbA1c Variant Analysis Mode
(predicate device) |
|-------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|
| Assay Principle | For Hemoglobin:
Conversion of all hemoglobin
derivatives into alkaline hematin
For HbA1c:
Latex agglutination inhibition | High Performance Liquid
Chromatography
(non-porous ion exchange) |
| Determination /
Calculation of results | Ratio of HbA1c/ Total Hemoglobin | Measurement of HbA1c as a
percentage of total hemoglobin |
| Calibration | Multipoint calibration (6 levels) for
Hemoglobin A1c
Single point calibration for Total
Hemoglobin | 2 point Calibration (high and low) |
| Analytical Range | 2.9 - 15.4% | 4.2 - 20.8% |
Calibrator Similarities
| | ADVIA Chemistry
A1c Calibrators
(new device) | VITROS Chemistry Products Calibrator
Kit 18
(predicate device) |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | For in vitro diagnostic use in the
calibration of the A1c and total
hemoglobin methods (Automated and
Manual Pretreatment) on the ADVIA
Chemistry Systems | For in vitro diagnostic use
only. VITROS Chemistry Products
Calibrator Kit 18 is used in conjunction
with VITROS Chemistry Products FS
Calibrator 1 to calibrate VITROS 5, 1
FS Chemistry Systems for the
calculation of percent glycated
hemoglobin (%A1c). |
| Calibrator Levels | 4 levels provided | 4 levels provided |
| Matrix / Ingredients | Processed human whole blood | Hemolysate derived from human and
ovine blood, surfactants, stabilizer, and
preservatives |
| Form | Lyophilized | Lyophilized |
| Storage | 2 - 8°C | 2 - 8°C |
| Shelf Life Stability | stable until the expiration date | stable until the expiration date |
| Reconstituted Vial /
Use Stability | 7 days stored at 2 - 8°C | 2 days stored at 2 - 8ºC |
Calibrator Differences
| | ADVIA Chemistry
A1c Calibrators
(new device) | VITROS Chemistry Products Calibrator
Kit 18
(predicate device) |
|---------------------------------------|----------------------------------------------------|----------------------------------------------------------------------|
| Instructions for Use
(Preparation) | Reconstitute with DI water before use | Reconstitute with diluent before use |
Siemens Healthcare Diagnostics (formerly Siemens Medical Solutions Diagnostics) ADVIA Chemistry Hemoglobin A1c Assay and Calibrators Premarket Notification - 510(k) 510(k) Summary .
4
Performance:
Substantial equivalence was demonstrated by testing several performance characteristics including imprecision, method comparison, interfering substances, matrix equivalency, and analytical range. The following tables summarize the precision (total), interfering substances, analytical range, and method comparison results.
All of the evaluation studies gave acceptable results compared to the Predicate Device. These studies support that the ADVIA Chemistry Hemoglobin A1c assay (with the ADVIA Chemistry A1c Calibrators) is substantially equivalent to the Tosoh G7 HPLC Hemoglobin A1c method that is currently marketed.
Imprecision
| ADVIA Chemistry
Hemoglobin A1c
ADVIA 1800 - Automated | | ADVIA Chemistry
Hemoglobin A1c
ADVIA 1800 - Manual | | Tosoh G7 HPLC
HbA1c | |
|-------------------------------------------------------------|-----------------|----------------------------------------------------------|-----------------|------------------------|-----------------|
| Level
HbA1c (%) | Total CV
(%) | Level
HbA1c (%) | Total CV
(%) | Level
HbA1c (%) | Total CV
(%) |
| 5.5 | 1.9 | 5.0 | 1.9 | 5.8 | 1.12 |
| 9.6 | 1.3 | 8.8 | 1.4 | 10.9 | 0.71 |
Correlation
(y = ADVIA Chemistry Hemoglobin A1c, x = comparison method/system)
| System (y) | N | Regression
Equation | r | Sy.x | Sample Range
(%) |
|------------------------------------------------------|----|------------------------|-------|------|---------------------|
| ADVIA 1800 Automated –
Least Squares | 80 | $y = 0.98x + 0.17$ | 0.997 | 0.17 | 4.40 - 12.60 |
| ADVIA 1800 Automated –
Passing Bablok / Pearson's | 80 | $y = 1.00x + 0.06$ | 1.00 | -- | 4.40 - 12.60 |
| ADVIA 1800 Manual –
Least Squares | 80 | $y = 0.95x + 0.26$ | 0.995 | 0.19 | 4.40 - 12.60 |
| ADVIA 1800 Manual –
Passing Bablok / Pearson's | 80 | $y = 0.97x + 0.10$ | 1.00 | -- | 4.40 - 12.60 |
x = NGSP Reference Method (Tosoh G7), y = ADVIA Chemistry System
Interfering Substances (ADVIA Chemistry Hemoglobin A1c on ADVIA 1800)
Automated Sample Pretreatment
| Interfering Substance | Interferent Conc.
(mg/dL) | HbA1c conc.
(%) | Effect
(% change) |
|----------------------------|------------------------------|--------------------|----------------------|
| Triglycerides (Intralipid) | 500 mg/dL | 5.2 | - 7.8 |
| Bilirubin, free | 60 mg/dL | 5.3 | - 1.9 |
| Bilirubin, conjugated | 60 mg/dL | 5.2 | - 3.8 |
Siemens Healthcare Diagnostics (formerly Siemens Medical Solutions Diagnostics) ADVIA Chemistry Hemoglobin A1c Assay and Calibrators Premarket Notification - 510(k) 510(k) Summary
Page 5 of 6
5
Manual Sample Pretreatment
| Interfering Substance | Interferent Conc.
(mg/dL) | HbA1c conc.
(%) | Effect
(% change) |
|----------------------------|------------------------------|--------------------|----------------------|
| Triglycerides (Intralipid) | 500 mg/dL | 5.2 | - 7.7 |
| Bilirubin, free | 60 mg/dL | 5.1 | - 2.0 |
| Bilirubin, conjugated | 60 mg/dL | 5.1 | - 5.9 |
| Rheumatoid Factor | 1100 IU/mL | 4.8 | 0 |
Analytical Range
| Platform | Analytical Range | ||
|---|---|---|---|
| All ADVIA Chemistry ' ' | - Galibrator Leval 6-(12-3-18.6%) | ||
| 1 -1 -1 -1 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- 2 -- | 2.4 /0 - | 10 |
Conclusions:
The ADVIA Chemistry Hemoglobin A1c method and Calibrators are substantially equivalent to other products in commercial distribution intended for similar use. Most notably, it is substantially equivalent to the currently marketed Tosoh G7 Automated HPLC Analyzer- HbA1c Variant Analysis Mode. The Tosoh G7 Automated HPLC Analyzer is certified by the National Glycohemoglobin Standardization Program (NGSP) and it is used as a reference method for establishing traceable results of other methods to the Diabetes Control and Complications Trial (DCCT).
The ADVIA Chemistry A1c Calibrators are substantially equivalent to the Predicate Device VITROS Chemistry Products Calibrator Kit 18.
6
Image /page/6/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an emblem featuring a stylized eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Siemens Healthcare Diagnostic c/o Dr. Philip Liu Manager, Regulatory Affairs and Compliance 511 Benedict Avenue Tarrytown, NY 10591
JAN - 8 2009
K081895 Re:
Trade/Device Name: ADVIA Chemistry Hemoglobin A1c Assay, ADVIA Chemistry
Alc Calibrators
Regulation Number: 21 CFR 864.7470 Regulation Name: Glycosylate hemoglobin assay. Regulatory Class: Class II Product Code: LCP, JIX Dated: November 18, 2008 Received: November 19, 2008
Dear Dr. Liu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820).
7
Page 2 -
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 594-3084. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Gregory C. Hammett, Ph.D.
Courthey C. Harper, Ph.D. Acting Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
8
Indication for Use
510(k) Number (if known): K081895
Device Name(s):
ADVIA® Chemistry Hemoglobin A1c ADVIA® Chemistry A1c Calibrators
Indications For Use:
The ADVIA® Chemistry Hemoglobin A1c method is for in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on the ADVIA Chemistry systems. Such measurements are used for monitoring the long-term glycemic control of persons with diabetes. The A1c and total hemoglobin (tHb) values generated as part of the HbA1cN and HbA1cI results are intended for use in the calculation of the A1c / total hemoglobin ratio, and must not be used individually for diagnostic purposes.
*Note: HbA1cN reports HbA1c in % and HbA1cI reports HbA1c in mmol/mol
The ADVIA® Chemistry A1c Calibrators are for in vitro diagnostic use in the calibration of the A1c and total hemoglobin methods (Automated and Manual Pretreatment) on the ADVIA Chemistry Systems.
Prescription Use X (21 CFR Part 801 Subpart D)
And/Or
Over the Counter Use (21 CFR Part 801 Subpart C),
(PLEASE DO NOT WRITE BELOW THIS LINE: CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)
Carol C. Benson
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K081895